About AMLAL PHARMACEUTICALS INC
Amlal Pharmaceuticals is developing cutting-edge small molecule therapeutics for brain cancers, focusing on enhancing the effectiveness of existing treatments while minimizing toxic side effects. Their approach targets GABA-A receptors in cancer cells to improve treatment outcomes for both pediatric and adult patients.
Development of small molecule therapeutics for brain cancersEnhancing the effectiveness of existing treatments like radiation, chemotherapy, and immunotherapyImproving blood-brain barrier penetrationModulating the tumor microenvironment to make tumors more responsive to immunotherapies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AMLAL PHARMACEUTICALS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.